Search Page

1

Cite

Share

Platelet-Derived Growth Factor Receptor and Ionizing Radiation in High Grade Glioma Cell Lines.

Alexandru O, Sevastre AS, Castro J, Artene SA, Tache DE, Purcaru OS, Sfredel V, Tataranu LG, Dricu A. Alexandru O, et al. Among authors: purcaru os. Int J Mol Sci. 2019 Sep 20;20(19):4663. doi: 10.3390/ijms20194663. Int J Mol Sci. 2019. PMID: 31547056 Free PMC article.

Cite

Share

2

Cite

Share

OMERACT Filter Evidence Supporting the Measurement of At-work Productivity Loss as an Outcome Measure in Rheumatology Research.

Beaton DE, Dyer S, Boonen A, Verstappen SM, Escorpizo R, Lacaille DV, Bosworth A, Gignac MA, Leong A, Purcaru O, Leggett S, Hofstetter C, Peterson IF, Tang K, Fautrel B, Bombardier C, Tugwell PS. Beaton DE, et al. Among authors: purcaru o. J Rheumatol. 2016 Jan;43(1):214-22. doi: 10.3899/jrheum.141077. Epub 2015 Sep 1. J Rheumatol. 2016. PMID: 26329339 Review.

Cite

Share

3

Cite

Share

Comparative effect of immunotherapy and standard therapy in patients with high grade glioma: a meta-analysis of published clinical trials.

Artene SA, Turcu-Stiolica A, Ciurea ME, Folcuti C, Tataranu LG, Alexandru O, Purcaru OS, Tache DE, Boldeanu MV, Silosi C, Dricu A. Artene SA, et al. Among authors: purcaru os. Sci Rep. 2018 Aug 7;8(1):11800. doi: 10.1038/s41598-018-30296-x. Sci Rep. 2018. PMID: 30087385 Free PMC article.

Cite

Share

4

Cite

Share

Improvements in workplace and household productivity with certolizumab pegol treatment in axial spondyloarthritis: results to week 96 of a phase III study.

van der Heijde D, Braun J, Rudwaleit M, Purcaru O, Kavanaugh AF. van der Heijde D, et al. Among authors: purcaru o. RMD Open. 2018 Apr 9;4(1):e000659. doi: 10.1136/rmdopen-2018-000659. eCollection 2018. RMD Open. 2018. PMID: 29670761 Free PMC article.

Cite

Share

5

Cite

Share

Improvements in productivity and increased participation in daily activities over 52 weeks of certolizumab pegol treatment of rheumatoid arthritis: results of a Belgian observational study.

Westhovens R, Ravelingien I, Vandevyvere K, Pansar I, Purcaru O, Kumke T, Gyselbrecht L. Westhovens R, et al. Among authors: purcaru o. Acta Clin Belg. 2019 Oct;74(5):342-350. doi: 10.1080/17843286.2018.1509923. Epub 2018 Aug 30. Acta Clin Belg. 2019. PMID: 30160189

Cite

Share

6

Cite

Share

Modeled Health Economic Impact of a Hypothetical Certolizumab Pegol Risk-Sharing Scheme for Patients with Moderate-to-Severe Rheumatoid Arthritis in Finland.

Soini E, Asseburg C, Taiha M, Puolakka K, Purcaru O, Luosujärvi R. Soini E, et al. Among authors: purcaru o. Adv Ther. 2017 Oct;34(10):2316-2332. doi: 10.1007/s12325-017-0614-8. Epub 2017 Oct 3. Adv Ther. 2017. PMID: 28975568 Free PMC article.

Cite

Share

7

Cite

Share

Plasma levels of glucose and insulin in patients with brain tumors.

Alexandru O, Ene L, Purcaru OS, Tache DE, Popescu A, Neamtu OM, Tataranu LG, Georgescu AM, Tudorica V, Zaharia C, Dricu A. Alexandru O, et al. Among authors: purcaru os. Curr Health Sci J. 2014 Jan;40(1):27-36. doi: 10.12865/CHSJ.40.01.05. Epub 2013 Dec 29. Curr Health Sci J. 2014. PMID: 24791202 Free PMC article.

Cite

Share

8

Cite

Share

Response to: 'Let's stop fooling ourselves. In RA, only ACR/EULAR criteria define remission and equate with absence of disease!' by Boers.

Emery P, Bingham CO 3rd, Burmester GR, Bykerk VP, Furst DE, Mariette X, Heijde Dv, Vollenhoven Rv, Arendt C, Mountian I, Purcaru O, Tatla D, VanLunen B, Weinblatt ME. Emery P, et al. Among authors: purcaru o. Ann Rheum Dis. 2016 Oct;75(10):e69. doi: 10.1136/annrheumdis-2016-210083. Epub 2016 Aug 12. Ann Rheum Dis. 2016. PMID: 27519773 Free article. No abstract available.

Cite

Share

9

Cite

Share

Worker productivity outcome measures: OMERACT filter evidence and agenda for future research.

Tang K, Boonen A, Verstappen SM, Escorpizo R, Luime JJ, Lacaille D, Fautrel B, Bosworth A, Cifaldi M, Gignac MA, Hofstetter C, Leong A, Montie P, Petersson IF, Purcaru O, Bombardier C, Tugwell PS, Beaton DE. Tang K, et al. Among authors: purcaru o. J Rheumatol. 2014 Jan;41(1):165-76. doi: 10.3899/jrheum.130815. Epub 2013 Oct 15. J Rheumatol. 2014. PMID: 24128774

Cite

Share

10

Cite

Share

Cost-Effectiveness of Certolizumab Pegol in the Treatment of Active Rheumatoid Arthritis, Axial Spondyloarthritis, and Psoriatic Arthritis In Romania.

Codreanu C, Mogosanu C, Joita M, Purcaru O. Codreanu C, et al. Among authors: purcaru o. Value Health. 2014 Nov;17(7):A379. doi: 10.1016/j.jval.2014.08.2608. Epub 2014 Oct 26. Value Health. 2014. PMID: 27200835 Free article. No abstract available.

Cite

Share